Lv3
304 积分 2024-11-06 加入
The next generation of immunotherapies for lung cancers
18小时前
待确认
Beyond checkpoint inhibitors: the three generations of immunotherapy
23小时前
已完结
New immune cell engagers for cancer immunotherapy
23小时前
已完结
“Innovations in Cancer Immunotherapy: A Comprehensive Overview of Recent Breakthroughs and Future Directions"
23小时前
已完结
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2–Based Immunotherapies
1天前
已完结
Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome
1天前
已完结
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses
1天前
已完结
Biomarkers to predict the clinical efficacy of bevacizumab in cancer
6天前
已完结
Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients
14天前
已完结
Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma
26天前
已完结
皖公网安备34019202002308
